Recommended treatment for hospitalized patients with COVID-19
| Mild or moderate | Severe | Critical | ||
|---|---|---|---|---|
| Features | Symptoms Oxygen saturation ≥ 94% | Oxygen saturation < 94% Respiratory rate ≥ 30 breaths/min Lung infiltrates on chest radiography > 50% | Respiratory failure requiring high-flow nasal cannula or noninvasive mechanical ventilation | Respiratory failure requiring invasive mechanical ventilation or extracorporeal membrane oxygenation |
| Isolation | Yes | Yes | Yes | Yes |
| Treatment | Remdesivir | Remdesivir plus dexamethasone | Dexamethasone with or without remdesivir Consider an immune modulator | Dexamethasone plus baricitinib, tofacitinib, or tocilizumab |
Based on information in reference 1.